Windham Capital Partners
Venture capitalNew York · Series A–Growth · 17 people tracked
Also known as WINDHAM CAPITAL PARTNERS LLC
Investment thesis
The firm relies on strategic relationships across the pharmaceutical, medical device, and digital health sectors, along with connections to leading life sciences venture funds, entrepreneurs, and clinical and scientific thought leaders. It uses this network to access and build disruptive healthcare technology companies, subjecting opportunities to intensive due diligence. The firm targets companies addressing unmet medical needs in large markets that promise to change healthcare, improve patient care, and extend life, with the goal of delivering significant returns to its investors.
Source: firm website, verified Aug 3, 2026.
Team · 17 people
from the firm's website & public directories
.jpg)
%20(002)%20(1).jpg)
What they invest in
from 21 of 48 portfolio companiesHealthtech ×18Biotech ×8Medical Devices ×8Digital Health ×5AI & Machine Learning ×3Enterprise Software ×2Mental Health ×2SaaS ×2
HQs:United States×21
Investments · 48 tracked
founders shown can be your intro pathAlto Neuroscience is a precision psychiatry company developing personalized drug treatments for people with neuropsychiatric conditions, using neuroscience research and clinical data to match patients to appropriate therapies.
BiotechDigital HealthMental HealthMountain View, US
Adam Savitz(Executive Officer)Amit Etkin(Founder)Nicholas C. Smith(Executive Officer)Gwill York(Director)Husseini Manji(Director)Christopher Nixon Cox(Director)
CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
BiotechHealthtechMedical DevicesAustin, US
Craig Palmer(Executive Officer)Geoff Pardo(Director)Nadim Yared(Executive Officer, Director)Dean Bruhn-Ding(Executive Officer)John Brintnall(Executive Officer)Liz Galle(Executive Officer)
Mentorship-driven startup accelerator for health technology entrepreneurs with funding and co-working space.
HealthtechAlpharetta, US
Carribeth Ramey(Executive Officer)Peter J. Pizzo(Executive Officer)Richard B. Knostman(Director)Ryan Drant(Director)Robert R. Singer(Executive Officer)Justin Klein(Director)
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US
Aditya Rajagopal(Director)Paul Flook(Executive Officer, Director)James C. Blair(Director)Gregory J. Gosch(Executive Officer, Director)Axel Scherer(Director)Alexander G. Dickinson(Director)
Medical device company developing the HARMONI Modular Intra-Ocular System for vision optimization in cataract surgery.
Medicare Advantage plan offering culturally sensitive healthcare combining Eastern and Western medicine.
Clever Care is a culturally and linguistically sensitive Medicare Advantage health plan serving Southern California that integrates Eastern and Western medicine approaches.
HealthtechInsurTechSouthern California, US
Myong Sun Lee(Executive Officer, Director)Hiep Dinh Pham(Executive Officer, Director)Dave Firdaus(Executive Officer, Director)
HealthtechRadnor, US
Steven Nichtberger(Director)Amir Yaron(Director)Harlan Weisman(Director)Guillaume Bailliard(Executive Officer, Director)Allon Guez(Director)Haim Melman(Director)
Burlington, US
Jerome Chevalier(Director)Joshua Makower(Director)Frederic Levy(Executive Officer, Director)Greg Lambrecht(Executive Officer, Director)
New York, US
Joseph Mayer(Director)James Bradley(Director)Bharath Ganesan(Director)Richard Resnick(Executive Officer, Director)Todd Pietri(Director)
BoardJohn Clarke(Director)
DELFI Diagnostics develops FirstLook Lung, a blood-based laboratory test for lung cancer screening that identifies genome-wide alterations in individuals eligible for screening.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBaltimore, US
Peter Bach(Executive Officer)Elizabeth Homans(Director)Rishi Gupta(Director)Justin Kao(Director)Jennifer Buechel(Executive Officer)Victor Velculescu(Executive Officer, Director, Promoter)
Detection on the Spot technology for food allergen detection spanning industrial and consumer applications.
Earlens develops a hearing aid that vibrates the eardrum directly instead of using speakers to amplify sound, enabling amplification across a broad audible frequency range including higher frequencies important for speech understanding.
HardwareHealthtechMedical DevicesMenlo Park, US
William M. Facteau(Executive Officer, Director)Bernard Shay(Executive Officer)Rodney Perkins, M.D.(Director)Henry Plain, Jr.(Director)Phil Lyons(Executive Officer)Steven A. Elms(Director)
Provides functional information about mutations and drug responses to enable precision oncology treatments.
HealthtechSan Diego, US
SAMUEL V. GOEKJIAN(Director)JOSEPH Y. LUCISANO(CHIEF TECHNOLOGY OFFICER)WILLIAM H. MARKLE(PRESIDENT AND CEO)ROBERT L. ENGLER(Director)ADAM E. FINE(Director)KNOX BELL(SECRETARY)
Sophisticated optics for illumination and enhanced visualization in surgical procedures.
Company improving human health through digital healthcare solutions using ultra-thin flexible body-worn sensors and advanced analytics.
Lexington, US
Alice Sansone(Executive Officer)Marc Singer(Director)Jiong Ma(Director)Paul Klingenstein(Director)Carmichael Roberts(Director)John Rogers(Director)
HealthtechPleasanton, US
Theodore Lamson(Director)Robert W. Croce(Director)Robert K. Anderson(Director)Ryan Drant(Director)David Amerson(Executive Officer, Director)Kadir Kadhiresan(Director)
Developing injectable neuromodulation devices using licensed mid-field powering technology.
Neuspera develops an integrated sacral neuromodulation system for treating urinary urge incontinence, using a smart implanted neurostimulator paired with a wireless external battery.
BiotechHealthtechMedical DevicesSan Jose, US
Milton M. Morris(Executive Officer, Director)
Nuvaira is a privately held medical device company that develops the dNerva Lung Denervation System, a catheter-based technology used in Targeted Lung Denervation to treat overactive airway nerves in patients with obstructive lung diseases such as COPD and asthma.
HealthtechMedical DevicesMinneapolis, US
Geoffrey Duyk(Director)Doug Sisson(Director)Timothy Herbert(Director)Dennis W. Wahr(Executive Officer, Director)Kirk Nielsen(Director)Dave Stassen(Director)
Personalized diagnostics leader with proprietary next-generation sequencing methodology for research and clinical oncology.
Revelle Aesthetics develops and commercializes the Avéli device, a precision medical technology for cellulite reduction.
FemTechMedical Devices
Eb Bright(Co-Founder and Chief Administrative Officer)Jonathan Podmore(Co-Founder and Chief Technology Officer)
HealthtechWilmington, US
Raeanna Lewarne(Executive Officer, Director)Shlomi Aflalo(Executive Officer, Director)Ori Karev(Director)Yishai Knobel(Executive Officer, Director)
BoardAdam Fine(Director)Gregg Dearhammer(Director)
Science Exchange provides operational infrastructure for life sciences R&D, connecting organizations, suppliers, and workflows to streamline contracting, compliance, onboarding, and financial coordination across the research ecosystem.
BiotechEnterprise SoftwareHealthtechSaaSSan Francisco, US
Elizabeth Iorns(Founder/President & CEO; Chairman of the Board)inDan Knox(Founder & COO)inMark Layden(CEO & Chairman)
SubjectWell operates a patient network that links individuals to clinical trials and connects them with healthcare providers and pharmaceutical sponsors.
BiotechDigital HealthHealthtech
Valeera Health provides virtual mental health care for adults and children, offering treatment plans developed by vetted in-house providers using data-driven clinical practices.
Digital HealthHealthtechMental HealthBrooklyn, US
Craig Albright(Executive Officer, Director)Arick Rynearson(Director)Ofer Sharon(Director)Thomas Tsang(Executive Officer, Director)
BoardAdam Fine(Director)James Nahirny(Director)
Developing a fluorescent probe to illuminate cancerous tissue during surgery for more accurate tumor resection.
HealthtechSunnyvale, US
John Pavlidis(Executive Officer, Director)David McIntyre(Director)Roy Tanaka(Director)A. Jay Graf(Director)Justin Klein(Director)Sami Hamade(Director)
Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.
AI & Machine LearningDigital HealthHealthtechBaltimore, US
Kevin McRaith(President and CEO)Anand Iyer(Chief AI Officer)David Levy(Director)Ryan Sysko(Executive Officer, Director)Terry Lierman(Director)Suzanne Clough(Executive Officer)
Frequently asked questions
- What stage does Windham Capital Partners invest at?
- Windham Capital Partners invests at the Series A, Series B, Series C, Growth stages.
- What sectors does Windham Capital Partners focus on?
- Windham Capital Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Windham Capital Partners located?
- Windham Capital Partners is headquartered in New York, US.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
OneVentures is a later-stage venture capital firm that backs technology and healthcare companies, providing growth equity and credit alongside strategic and operational support.